Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Taurine and Reduced Fasting Blood Glucose Levels

Doses used in studies

g/day: 0.5–6 (median 3.13, IQR 1.13–5.25) — 2 studies

Time to effect

Median: 5 days · IQR 5 days–5 days · Range 5 days–5 days — Reported in 1 of 2 studies

2 of 2 papersPopulation:

Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
- 2024-05-16
- Meta-Analysis · n = 1,024
- Nutrition & diabetes 14(1)
- - Chih-Chen Tzang
  - Liang-Yun Chi
  - Long-Huei Lin
  - Ting-Yu Lin
  - Ke-Vin Chang
  - Wei-Ting Wu
  - Levent Özçakar
- PubMed: 38755142
- DOI: 10.1038/s41387-024-00289-z
6 Insights on
- Reduced Fasting Blood Glucose Levels
- High evidence
taurine supplementation demonstrated statistically significant reductions in ... FBG (WMD: -5.882 mg/dL, 95% CI: -10.747 to -1.018, p = 0.018)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
0.5 g/day to 6 g/day
Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.
- 2024-12-27
- Meta-Analysis
- Nutrients 17(1)
- - Qin Sun
  - Jieping Wang
  - Huanyu Wang
  - Hanhan Yu
  - Kang Wan
  - Fuyi Ma
  - Ru Wang
- PubMed: 39796489
- DOI: 10.3390/nu17010055
7 Insights on
- Reduced Fasting Blood Glucose Levels
- High evidence
- Rigorous Journal
- Clinical
long-term intake of 3 g of taurine significantly improved ... FPG levels (WMD = -7.14 mg/dL, 95% CI: -12.53 to -1.74, p = 0.003, I² = 70%) in overweight/obesity
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
3 g/day